CURE vs. LULG
CURE (Direxion Daily Healthcare Bull 3x Shares) and LULG (Leverage Shares 2X Long LULU Daily ETF) are both Leveraged Equities funds. CURE is passively managed, while LULG is actively managed. At a 0.30 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.75%/yr for LULG.
Performance
CURE vs. LULG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -3.98% return, which is significantly higher than LULG's -75.54% return.
CURE
- 1D
- 4.52%
- 1M
- 14.41%
- YTD
- -3.98%
- 6M
- -6.03%
- 1Y
- 39.34%
- 3Y*
- 4.46%
- 5Y*
- 1.58%
- 10Y*
- 15.35%
LULG
- 1D
- -1.81%
- 1M
- -25.41%
- YTD
- -75.54%
- 6M
- -76.28%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CURE vs. LULG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -3.98% | 20.29% |
LULG Leverage Shares 2X Long LULU Daily ETF | -75.54% | 55.59% |
Correlation
The correlation between CURE and LULG is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 5, 2025 | 0.30 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. LULG — Risk / Return Rank
CURE
LULG
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
CURE vs. LULG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Leverage Shares 2X Long LULU Daily ETF (LULG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | LULG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.17 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.27 | — | — |
| Martin ratioReturn relative to average drawdown | 2.81 | — | — |
Loading charts...
Drawdowns
CURE vs. LULG - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum LULG drawdown of -79.88%. Use the drawdown chart below to compare losses from any high point for CURE and LULG.
Loading charts...
Drawdown Indicators
| CURE | LULG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -79.88% | +10.69% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | — | — |
Current DrawdownCurrent decline from peak | -23.78% | -77.35% | +53.57% |
Average DrawdownAverage peak-to-trough decline | -18.18% | -37.21% | +19.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.04% | — | — |
Volatility
CURE vs. LULG - Volatility Comparison
Loading charts...
Volatility by Period
| CURE | LULG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.54% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 31.42% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 44.65% | 88.29% | -43.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.97% | 88.29% | -44.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.58% | 88.29% | -38.71% |
CURE vs. LULG - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than LULG's 0.75% expense ratio.
Dividends
CURE vs. LULG - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.18%, while LULG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.18% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
LULG Leverage Shares 2X Long LULU Daily ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CURE and LULG have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, LULG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LULG is cheaper with a 0.75% expense ratio, compared with 1.08% for CURE.
CURE has the higher dividend yield at 1.18%, compared with 0.00% for LULG.
They also come from different issuers: Direxion and Leverage Shares. Their fees differ too: 1.08% for CURE and 0.75% for LULG.
Find the right allocation for CURE and LULG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer